Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in ABEO — Abeona Therapeutics Inc.

CIK 1115418 BOSTON, MA
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$350,721
+$100,527 QoQ
Shares Held
56,751
+1.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 125 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. ABEO ranks #208 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in ABEO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $350,721 56,751
2026-03-31 $250,194 55,847
2025-12-31 $294,756 55,931
2025-09-30 $336,193 63,673
2025-06-30 $383,428 67,505
2025-03-31 $8,825 1,854
2024-12-31 $10,326 1,854
2024-09-30 $11,717 1,854
2024-06-30 $228 54
2024-03-31 $420 58
2023-12-31 $290 58
2023-09-30 $244 58
2023-06-30 $233 58
2021-03-31 $168,963 89,874
2020-12-31 $141,102 89,874
2020-09-30 $76,066 74,575
2020-06-30 $259,564 88,892
2020-03-31 $149,669 71,271